Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Sack

Showing results (51-60 of 277) with videos related to

Pageof 28
Sort By:
Clinical Microbiology Reviews|January 16, 2007
Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariantsG Balakrish Nair, Thandavarayan Ramamurthy, Sujit K Bhattacharya, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2003
CTXphi-independent production of the RS1 satellite phage by Vibrio choleraeShah M Faruque, M Kamruzzaman, Asadulghani, et al.
International Journal of Epidemiology|May 26, 2006
Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunityMichael Emch, Mohammad Ali, Jin-Kyung Park, et al.
Bulletin of the World Health Organization|August 4, 2009
Improving international research contractingDavid A Sack, Vanessa Brooks, Michael Behan, et al.
Vaccine|November 1, 2005
Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groupsFirdausi Qadri, Tanvir Ahmed, Firoz Ahmed, et al.
Vaccine|May 15, 2003
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of ageFirdausi Qadri, Tanvir Ahmed, Firoz Ahmed, et al.
The Lancet. Infectious Diseases|December 4, 2003
Multidrug-resistant Shigella dysenteriae type 1 in south AsiaS K Bhattacharya, K Sarkar, G Balakrish Nair, et al.
Maternal & Child Nutrition|June 27, 2013
Double-blind cluster randomised controlled trial of wheat flour chapatti fortified with micronutrients on the status of vitamin A and iron in school-aged children in rural BangladeshAhmed S Rahman, Tahmeed Ahmed, Faiz Ahmed, et al.
Vaccine|April 24, 2012
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in BangladeshAndrea J Feller, K Zaman, Kristen D C Lewis, et al.
Journal of Clinical Microbiology|July 8, 2005
Characterization of a novel P[25],G11 human group a rotavirusMustafizur Rahman, Jelle Matthijnssens, Sharifun Nahar, et al.
Pageof 28

Showing results (51-60 of 277) with videos related to

Sort By:
Pageof 28
Clinical Microbiology Reviews|January 16, 2007
Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariantsG Balakrish Nair, Thandavarayan Ramamurthy, Sujit K Bhattacharya, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2003
CTXphi-independent production of the RS1 satellite phage by Vibrio choleraeShah M Faruque, M Kamruzzaman, Asadulghani, et al.
International Journal of Epidemiology|May 26, 2006
Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunityMichael Emch, Mohammad Ali, Jin-Kyung Park, et al.
Bulletin of the World Health Organization|August 4, 2009
Improving international research contractingDavid A Sack, Vanessa Brooks, Michael Behan, et al.
Vaccine|November 1, 2005
Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groupsFirdausi Qadri, Tanvir Ahmed, Firoz Ahmed, et al.
Vaccine|May 15, 2003
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of ageFirdausi Qadri, Tanvir Ahmed, Firoz Ahmed, et al.
The Lancet. Infectious Diseases|December 4, 2003
Multidrug-resistant Shigella dysenteriae type 1 in south AsiaS K Bhattacharya, K Sarkar, G Balakrish Nair, et al.
Maternal & Child Nutrition|June 27, 2013
Double-blind cluster randomised controlled trial of wheat flour chapatti fortified with micronutrients on the status of vitamin A and iron in school-aged children in rural BangladeshAhmed S Rahman, Tahmeed Ahmed, Faiz Ahmed, et al.
Vaccine|April 24, 2012
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in BangladeshAndrea J Feller, K Zaman, Kristen D C Lewis, et al.
Journal of Clinical Microbiology|July 8, 2005
Characterization of a novel P[25],G11 human group a rotavirusMustafizur Rahman, Jelle Matthijnssens, Sharifun Nahar, et al.
Pageof 28